Beyond regulatory hurdles, Anthropic now faces a growing political challenge.
As the firm gears up for one of the most anticipated technology stock market debuts in recent memory, its chief executive is increasingly finding himself in the political crosshairs in Washington.
An internal memo, cited by Axios, characterizes Amodei and his associates as part of an isolated faction promoting an exaggerated perspective on artificial intelligence hazards. An official within the administration noted that Amodei’s philosophy runs counter to Donald Trump’s vision for artificial intelligence.
The Timing is Awkward for Anthropic
During a United Nations Security Council briefing on September 23, Amodei warned that sophisticated AI systems might present “a risk to humanity as a whole,” adding that Anthropic would consider decelerating its research.
In the same meeting, Michael Kratsios, the White House science adviser, reportedly dismissed international oversight of artificial intelligence as a “globalist scheme.”
This public disagreement now trails Anthropic as it prepares to enter the public equities market. Previously, Trump targeted Amodei on Truth Social following the executive’s public statements advocating for a slower pace in frontier AI development.
Market participants are increasingly grappling with a central dilemma: what level of political exposure accompanies Anthropic’s commitment to safety?
A Question About Anthropic’s Internal Ideology
Anthropic has consistently pushed back against claims that effective altruism shapes its corporate identity. Company president Daniela Amodei stated that she rejects the description, and Dario Amodei has disavowed any formal connection to the philosophy.
Reports indicate the enterprise has pushed back its initial public offering from October to November, with potential valuations hovering near $2 trillion. Certain financial backers already view this political friction as an additional vulnerability for the upcoming market entry.